CONMED Corporation (NYSE:CNMD) — Market Cap & Net Worth
Market Cap & Net Worth: CONMED Corporation (CNMD)
CONMED Corporation (NYSE:CNMD) has a market capitalization of $1.11 Billion ($1.11 Billion) as of May 5, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #8691 globally and #2340 in its home market, demonstrating a -6.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CONMED Corporation's stock price $35.88 by its total outstanding shares 30833536 (30.83 Million). Analyse CONMED Corporation operating cash flow efficiency to see how efficiently the company converts income to cash.
CONMED Corporation Market Cap History: 2015 to 2026
CONMED Corporation's market capitalization history from 2015 to 2026. Data shows change from $1.24 Billion to $1.11 Billion (-2.18% CAGR).
Index Memberships
CONMED Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.53 Trillion | 0.14% | #441 of 602 |
Weight: CONMED Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CONMED Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CONMED Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.91x
CONMED Corporation's market cap is 0.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
26.60x
CONMED Corporation's market cap is 26.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.26 Billion | $763.52 Million | $14.66 Million | 1.65x | 86.10x |
| 2017 | $1.48 Billion | $796.39 Million | $55.49 Million | 1.86x | 26.70x |
| 2018 | $1.89 Billion | $859.63 Million | $40.85 Million | 2.20x | 46.19x |
| 2019 | $3.32 Billion | $955.10 Million | $28.62 Million | 3.47x | 115.86x |
| 2020 | $3.35 Billion | $862.46 Million | $9.52 Million | 3.89x | 352.48x |
| 2021 | $4.27 Billion | $1.01 Billion | $62.54 Million | 4.23x | 68.31x |
| 2022 | $2.69 Billion | $1.05 Billion | -$80.58 Million | 2.58x | N/A |
| 2023 | $3.35 Billion | $1.24 Billion | $64.46 Million | 2.69x | 51.98x |
| 2024 | $2.11 Billion | $1.31 Billion | $132.42 Million | 1.61x | 15.94x |
| 2025 | $1.25 Billion | $1.37 Billion | $47.05 Million | 0.91x | 26.60x |
Competitor Companies of CNMD by Market Capitalization
Companies near CONMED Corporation in the global market cap rankings as of May 5, 2026.
Key companies related to CONMED Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #145 globally with a market cap of $152.22 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #211 globally with a market cap of $111.32 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #229 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (XETRA:2M6): Ranked #236 globally with a market cap of $101.71 Billion USD ( €87.00 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #145 | Abbott Laboratories | NYSE:ABT | $152.22 Billion | $87.54 |
| #211 | Stryker Corporation | NYSE:SYK | $111.32 Billion | $290.88 |
| #229 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | XETRA:2M6 | $101.71 Billion | €67.76 |
CONMED Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, CONMED Corporation's market cap moved from $1.24 Billion to $ 1.11 Billion, with a yearly change of -2.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.11 Billion | -11.63% |
| 2025 | $1.25 Billion | -40.68% |
| 2024 | $2.11 Billion | -37.02% |
| 2023 | $3.35 Billion | +24.45% |
| 2022 | $2.69 Billion | -36.98% |
| 2021 | $4.27 Billion | +27.35% |
| 2020 | $3.35 Billion | +1.16% |
| 2019 | $3.32 Billion | +75.71% |
| 2018 | $1.89 Billion | +27.39% |
| 2017 | $1.48 Billion | +17.33% |
| 2016 | $1.26 Billion | +2.19% |
| 2015 | $1.24 Billion | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of CONMED Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.11 Billion USD |
| MoneyControl | $1.11 Billion USD |
| MarketWatch | $1.11 Billion USD |
| marketcap.company | $1.11 Billion USD |
| Reuters | $1.11 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation an… Read more